Each film-coated tablet contains: Anastrozole 1 mg.
Pharmacology: Pharmacokinetics: Anastrozole is generally well tolerated and the most frequent adverse effects are gastro-intestinal disturbances including anorexia, nausea and vomiting, and diarrhea; asthenia; hot flushes; dizziness; drowsiness; headache; and rash. Other reported effects including hair thinning, vaginal dryness or bleeding, oedema, myalgia and arthralgia, fever, thrombophlebitis, leucopenia, and flu-like syndrome. Abnormalities in liver enzyme values have occurred in some patients receiving Anastrozole.
Anastrozole is indicated for the treatment of breast cancer in postmenopausal women.
Should be used in a dose of 1 mg daily or as directed by the physician.
The use of Anastrozole is contra-indicated in pre-menopausal women. It is not known whether it can be safely given to patients with moderate or severe hepatic impairment, or severe renal impairment.
Store at temperatures not exceeding 30°C.
Protect from light and moisture.
L02BG03 - anastrozole ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.